BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
Orally active Raf kinase inhibitor from Onyx/Bayer in phase I clinical trials
May 9, 2001
Potency of several retinoids assessed in bladder cancer cell lines
May 9, 2001
Enzon begins patient treatment in phase I trial of PEG-paclitaxel
May 9, 2001
MGI's lead acylfulvene advances to phase II for refractory sarcoma
May 9, 2001
Preclinical profile of Bay-59-8862, a new taxane, reviewed in Drugs of the Future
May 8, 2001
MAbs prepared at Genentech act as HGF receptor antagonists
May 8, 2001
Cell Pathways and BMS to initiate drug combination study for first-line NSCLC
May 8, 2001
Preclinical antiproliferative activity of A-105972 characterized
May 8, 2001
Phase II trial of irofulven for treatment of glioma commences
May 8, 2001
Pharmacyclics reacquires worldwide rights to Lutrin
May 8, 2001
Previous
1
2
…
3654
3655
3656
3657
3658
3659
3660
3661
3662
…
4114
4115
Next
RSS